Emtricitabine |
Emtriva |
Emtricitabine Systematic (IUPAC) name 4-amino-5-fluoro-1- [2-(hydroxymethyl)- 1,3-oxathiolan-5-yl]- pyrimidin-2-one Identifiers CAS number 143491-57-0 ATC code J05AF09 PubChem 60877 DrugBank APRD00226 Chemical data Formula C8H10FN3O3S Mol. weight 247.248 g/mol Pharmacokinetic data Bioavailability ? Protein binding Very low (less than 4%) Metabolism ? Half life 10 hours Excretion ? Therapeutic considerations Pregnancy cat. ? Leg ...
Wikipedia - [full article]
Emtricitabine News Headlines
- Bristol-Myers Squibb, Gilead Sciences And Merck & Co. Submit Marketing Authorisation Application For ATRIPLA(TM)
MedicalNewsToday - Tue, 10 Oct 2006 07:00 EST
- U.S. Food And Drug Administration (FDA) Approves ATRIPLA(TM) (efavirenz 600 Mg/ Emtricitabine 200 Mg/ Tenofovir Disoproxil Fumarate 300 Mg), For HIV-1
MedicalNewsToday - Fri, 14 Jul 2006 06:00 EST
- FDA Approves Atripla For HIV Infection, Once-a-day Tablet With Three Drug Combination
MedicalNewsToday - Thu, 13 Jul 2006 04:00 EST
- Tenofovir Plus Emtricitabine Combo May Protect From HIV Transmission
MedicalNewsToday - Tue, 28 Mar 2006 02:00 EST

Not Signed In -


